Anzeige
Mehr »
Login
Montag, 30.09.2024 Börsentäglich über 12.000 News von 692 internationalen Medien
Aktuelle News: Größter Player im Valley der 1.000%-er!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 907473 | ISIN: FR0000035784 | Ticker-Symbol: 36J
Frankfurt
30.09.24
08:10 Uhr
1,230 Euro
-0,080
-6,11 %
1-Jahres-Chart
TRANSITION EVERGREEN SA Chart 1 Jahr
5-Tage-Chart
TRANSITION EVERGREEN SA 5-Tage-Chart
RealtimeGeldBriefZeit
1,5601,59011:28
Actusnews Wire
441 Leser
Artikel bewerten:
(2)

TRANSITION EVERGREEN: 2024 half-year results

  • NAV[1]: €116.7m, down by 10.8% vs. 31 December 2023 (-14.1% from 30 June 2023) against a backdrop of high interest rates and low energy prices;
  • NAV per share at 30 June 2024: €2.91 (vs. €3.26 at 31 December 2023 and €3.39 at 30 June 2023);
  • During this first half, all the Company's investees continued to implement various financing options.

Paris - 30 September 2024 - 8:00 a.m.

Transition Evergreen (FR0000035784 - EGR), an evergreen fund listed in France on Euronext Paris, dedicated to the ecological transition and reducing the carbon footprint, reported its half-year results[2] and net asset value as of 30 June 2024, which were approved by the Board of Directors at its meeting held on 27 September 2024. The interim financial report for the period ended 30 June 2024 is available on Transition Evergreen's website, www.transition-evergreen.com, in the Investors section under Financial documents.

Lionel Le Maux, Chairman and Chief Executive Officer of Transition Evergreen, commented:

"The first half of 2024 was characterised by continued high interest rates and low energy prices. Both factors mechanically affected the net asset value (NAV) of the Transition Evergreen fund
(-11%), equally penalising companies under the ecological transition theme on the stock market during this period.

However, it should be noted that these external factors impacting NAV can be reversed: the easing of interest rates expected in the second half, along with numerous geopolitical tensions and their effect on energy prices are factors likely to have a favourable influence on valuations.

The strong appeal of the ecological transition industry is also worth highlighting, as illustrated by the most recent delistings in the sector which have underscored the strategic value of these asset classes. Notable examples include takeover bids for French renewables producer Neoen by Canadian fund Brookfield, the German energy company Encavis by US investment fund KKR, and the acquisition of the Swedish offshore wind project developer OX2 by private equity investor, EQT.

Such consolidation demonstrates the idea of critical mass in solar, wind, biogas and hydrogen, at a time when efforts to develop renewables are doubled down (USD$2,000 billion in investment is expected in clean energies by 2024, a level twice as high as that geared towards fossil fuels[3]).

This is the central focus of current discussions regarding Transition Evergreen investees. It specifically refers to the arrangement of suitable financing to accelerate growth (internal and external) in Biogas and Solar, as well as pursuing current industrialisation (mobility) and strengthening industry (management of natural heritage and wood energy).

At Transition Evergreen, influential stakeholders in the energy transition financing ecosystem are keen to support the scale-up of the Company's various platforms (Biogas, Solar, Wood Energy, Hydrogen).

As the main shareholder, we are backing all these initiatives, convinced that large-scale investment in the energy transition will also require a change of scale in actionable resources.

Going forward, during the rest of the 2024 financial year, we will continue to pay special attention to the ongoing development of our various investees, particularly boosting our "Infrastructure" assets, with a sustained focus on driving value creation within Transition Evergreen."

HALF-YEAR RESULTS

NAV[4] of €116.7m at 30 June 2024

Transition Evergreen's net asset value (NAV) amounted to €116.7m at 30 June 2024, vs. €130.8m at 31 December 2023 and €135.8m at 30 June 2023. The difference between 30 June 2024 and 31 December 2023 stemmed from (i) a change in the fair value of investees over the period (-€11.1m) and (ii) the result for the first half restated for the fair value effect (-€3.0m).

The latter does not include the conversion of a current account into preference shares in Safra, which was completed in July 2024.

As of 30 June 2024, NAV per ordinary share[5] amounted to €2.91[6] (vs. €3.26 at 31 December 2023 and €3.39 at 30 June 2023).

The fair value of investees amounted to €119.5m at 30 June 2024 versus €152.8m at 31 December 2023 (and €151.7m at 30 June 2023). This decline in value between 30 June 2024 and 31 December 2023 stemmed especially from:

  • differences in the valuation of Transition Evergreen investees - factoring in a less favourable market environment, marked by high interest rates and low energy prices. This context is factored into cash flow discounting methods and energy price assumptions (penalised by low spot prices), in addition to peer comparisons on the stock market (declining from 20% to 50% during this first half);
  • the sale of Transition Evergreen's 36% interest in 3E Biogas to Aqua SAS[7], in an effort to streamline organisation;
  • Everwood's issue of a bond convertible into shares on 31 May 2024, as subscribed by Transition Evergreen in the amount of €1.5m.

Restated for the accounting effect of the sale of 3 E Biogas (€23.7m reclassified as Other non-current assets7), the fair value of investees amounted to €143.2m at 30 June 2024 versus €152.8m at 31 December 2023.

2024 half-year results

First-half operating loss came out to -€12.0m at 30 June 2024. It includes:

  • -€11.1m in fair value adjustments to financial assets;
  • -€0.2m in staff costs;
  • -€1.7m in other operating costs;
  • +€1.0m in revenue from financial assets.

The cost of financial debt amounted to €(2.1)m versus €(0.9)m at 30 June 2023. It comprises interest on bonds €(2.0)m and current account advances €(0.1)m.

Overall net loss was €(14.1)m at 30 June 2024, versus €(2.3)m for the same period in 2023.

A detailed income statement as of 30 June 2024 is appended to page 6 of this press release.

Financial position

Transition Evergreen's shareholders' equity was €116.7m at 30 June 2024, compared with €130.8m at 31 December 2023, factoring in these half-year results.

Recent bond issues, grossing an amount of €27m[8], enabled the Company to continue investing in specific investees through current account contributions with the option of converting these into capital for a total of €12.2m (Safra for €9.8m[9], EverWatt for €1.6m and Keyrio for €2.5m, including €0.8m which was booked in the first half of 2024).

During the first half, Transition Evergreen also subscribed to EverWatt's bond issue (€1.5m), and proceeded to repayment of €2.6m in bond issues and paid financial interest over the period (€0.7m).

The Company's financial debt - comprising bond issues (with 83% of them maturing in more than 1 year) - amounted to €44.0m at 30 June 2024 versus €21.7m at 31 December 2023.

As of 30 June 2024, Transition Evergreen had available cash of €1.3m, versus €0.7m as of 31 December 2023. For the record, the Company has a maximum current account advance of €12m authorised by Financière Evergreen[10], €6.8m of which remains available.

A detailed balance sheet as of 30 June 2024 is appended to page 7 of this press release.

OUTLOOK

Update on investees

Transition Evergreen's investee projects continued to achieve robust growth.

Infrastructures segment

  1. Evergaz delivered an excellent performance at its 4 production sites, on the back of a full-scale renovation plan implemented at its "Bioenergaz" biomethane injection unit. Continuing this momentum, Evergaz kick-started a comprehensive industrial plan for the 34 plants in the portfolio which includes projects for expansion, construction and biomethane conversion to improve the business' performance. What's more, this plan paves the way for the development of new projects over the next six years, aimed at achieving critical mass for a strategic asset of this size. A financing agreement was reached with the main shareholders and capital-raising is underway to bolster this initiative.

  1. Groupe EverWatt recently secured €7.1m in bond financing from a pan-European asset manager with a view to supporting the development of a leasing solution to install solar panels for private individuals.

Even more recently and parallel to this, Groupe EverWatt and BoucL Energie were successful in a Call for Expression of Interest (CEI) launched by the City of Bordeaux to supply its submarine base with solar power. Photovoltaic panels spanning 13,200 m2 will be installed, generating 3.39 GWh of energy while avoiding 806 tonnes of CO2, both on an annual basis. The project falls within the scope of the Alliance de Bordeaux pour l'Énergie Solaire ("Bordeaux Solar Energy Alliance") which aims to equip the city with 60,000 m² of solar panels. As a third-party investor, BoucL Energie will finance the infrastructure, making some of the capital available to the City of Bordeaux to share management responsibilities.

pHYnix, which focuses on developing green hydrogen and related services, stepped up the expansion of its project pipeline on the Iberian peninsula, and also secured its electrical supply for its two flagship initiatives, namely Barataria and Vitale.

  1. Everwood has increased its global reach in forestry asset management since it acquired an interest in the American company F&W Forestry Services Inc. (F&W) in February this year.

Industry segment

  1. Safra latterly obtained an approval for its H2-PACK® kit, paving the way for wide-scale production of zero-emission, hydrogen-powered diesel coaches that only emit water vapour. Discussions are ongoing between the Company and its shareholders to identify and implement external financing during its next phase of mass production.

  1. Wooday, which seeks to produce and distribute wood-energy powered fuel, pursued its strategy to consolidate its market positioning as well as control the value chain (acquiring Bois Bûche Molinario in June 2024).

  1. LPF Groupe concentrated efforts on innovation, with renewed investment in its manufacturing facilities so as to maximise production capacity, maintain its technological edge and strengthen its presence in Italian luxury.

To conclude, for the remainder of 2024, Transition Evergreen will pursue its financial support to its investees in order that they sustain their growth trajectory and upscale from SMEs to become mid-cap companies, while giving priority to the "Infrastructures" segment (Evergaz, F&W, Groupe EverWatt and pHYnix) as outlined in its plan. In parallel, the fund maintains its focus on deploying financing solutions that are better suited to the needs and business models of the "Industry" segment (Safra, LPF Groupe, Wooday). Lastly, Transition Evergreen initiated the process to simplify its fund organisation, as mentioned in April (first transaction completed in this respect with 3 E Biogas - see above).

About Transition Evergreen

Transition Evergreen is an evergreen fund listed in France with a focus on accelerating the ecological transition and reducing
the carbon footprint.

Leveraging the expertise of asset management company, Aqua Asset Management, Transition Evergreen seeks to provide concrete solutions to the challenges of building a carbon-neutral world by investing in high-growth French and European SMEs focused on the ecological transition.

Transition Evergreen holds interests mainly in the following companies: Evergaz, the leading independent French biogas player, C4, a fully-integrated methanisation operator in Germany, EverWatt, an energy-efficient and carbon-neutral player for regions, Everwood, a specialist in sustainable forest management and Safra, a French player in the carbon-neutral mobility market.

Transition Evergreen has been awarded the Greenfin label, which guarantees the green credentials of investment funds and is awarded to funds that factor environmental, social and governance ("ESG") criteria into the design and life cycle of their portfolio, comply with the exclusion criteria set by the label and have a positive impact on the energy and ecological transition. Transition Evergreen has been awarded the "Relance" label for investment funds that support the economic recovery by strengthening French companies with equity or quasi-equity.

Transition Evergreen is listed on Euronext Paris, compartment C (ISIN FR0000035784). Transition Evergreen is eligible for the PEA-PME equity savings plan.

Learn more at www.transition-evergreen.com

Contacts

Transition Evergreen
Laura Ribeiro
T: +33 (1) 89.16.61.09
RI@transition-evergreen.com
Investor Relations
ACTUS finance & communication
Anne-Pauline Petureaux
T: +33 (1) 53 67 36 72
apetureaux@actus.fr
Media Relations
ALVA
Bérénice Weiss
T: +33 (6) 83 35 63 11
bweiss@alvaconseil.com

Disclaimer

It should be noted that any investment includes the risk of partial or total loss of the capital invested. For further information on the risks of investing in the portfolio, please refer to the "Risk Factors" section of the 2023 Universal Registration Document and the 2023 Annual Financial Report.

Recognition of extra-financial criteria is likely to encounter methodological limitations. In particular, there may be inconsistencies in investee reporting, owing to their size and stage of development.

Also note that past performance is no guarantee of future performance and performance is not constant over time.

APPENDICES

(€k)30/06/202330/06/2024
Revenue from financial assets541-1,056
Change in fair value of financial assets449-11,126
Payroll costs-242-203
Other operating costs-1,707-1,687
Operating profit (loss)-959-11,96
Gross cost of financial debt-890-2,082
Net cost of financial debt-890-2,082
Other financial income and expenses-48-35
Net profit (/loss) before tax-1,897-14,078
Income tax-3730
Net profit (/loss)-2,269-14,078

Number of shares in circulation*40,075,97340,043,753
Earnings per share (€)(0.06)(0.35)
Number of shares after dilution*40,075,97340,043,753
Diluted earnings per share (€) (0.06)(0.35)

*Excluding treasury shares

BALANCE SHEET

ASSETS (€k)31-12-2330-06-24
Non-current financial assets152,823119,473
- o/w shares152,823117,908
- o/w bonds 1,565
Other non-current assets1325,549
Total non-current assets152,836145,022
Current financial assets11,46921,646
Other receivables90694
Cash & cash equivalents6771,315
Total current assets12,23623,655
Total assets165,072168,676

LIABILITIES (€k)31-12-2330-06-24
Capital20,08620,086
Share capital premium34,01830,954
Reserves84,36879,737
Overall profit(7,685)(14,078)
Shareholders' equity130,786116,699
Non-current portion of bond issues14,44933,267
Deferred tax liabilities00
Total non-current liabilities14,44933,267
Bond issues7,28410,744
Other current financial liabilities7,6046,323
Other debts4,9491,644
Total current liabilities19,83718,711
Total assets165,072168,676

CHANGE IN THE FAIR VALUE OF INVESTEES SINCE 30 JUNE 2023

InvesteesFair value
30/06/2023
Fair value
31/12/2023
Fair value
30/06/2024
Everwood SAS €28,723k €26,461k €28,567k
Aqua SAS/Evergaz SA €26,900k €28,641k €23,753k
EverWatt SAS €43,016k €44,990k €41,604k
LPF Groupe SAS €4,230k €4,230k €4,171k
Valporte Holding SAS €1,876k €1,908k €1,908k
Borea SAS €342k €360k €249k
Safra SA €19,457k €19,809k €17,655k
Safra Participations SAS €3,330k--
3 E BIOGAS/C4 Group €23,724k €26,424k-
Keiryo SAS (formerly Green H2 Partenaires SAS) €130k--
Total share portfolio€151,729k€152,823k€117,908k
Total bond portfolio- €1,565k
Total assets€151,729k -€152,823k€119,473k


[1] NAV: net asset value corresponds to the Company's IFRS shareholder equity, i.e. €116.7m. The change between 30 June 2024 and 31 December 2023 stemmed from the change in the fair value of investees during the period (-€11.1m) and the result for the first half excluding the fair value effect (-€3.0m).

[2] The statutory auditors conducted a limited review.

[3] International Energy Agency (IEA) 2023 Annual Report.

[4] NAV: net asset value corresponds to the Company's IFRS shareholder equity, i.e. €116.7m (vs. €130.8m at 31 December 2023 and €135.8m at 30 June 2023).

[5] Excluding treasury shares.

[6] Identical before and after dilution in the absence of a dilutive instrument outstanding at the given date.

[7] March 2024 saw Transition Evergreen sell its stake in 3 E Biogas to Aqua SAS, which already owned 27.31% of the shares in Evergaz. The purpose of this transaction is to consolidate the entire Biogas division under a single entity. As a reminder, Aqua SAS is 100% owned by Transition Evergreen. This sale had a negative impact of €23.7m on the fair value of investees, resulting in a receivable from Aqua SAS for the same amount in Transition Evergreen's balance sheet under "Other non-current assets" which can be repaid over 3 years.

[8] Two ordinary bond (OB) issues - one for a gross amount of €7m issued in January and February 2024 (Tranche C2 of OB 9) and the other grossing €20m issued in March 2024 to a single investor (ZENCAP OB)

[9] After closing the half-year, under the terms of the Memorandum of Understanding (MoU), Transition Evergreen's partner current account with SAFRA was converted into preference shares. Transition Evergreen now owns a 34.79% stake in SAFRA.

[10] A 0.78% shareholder in Transition Evergreen as of 31 December 2023.

------------------------
This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: m2ufkspslmqdl21rlJlnbWhpb2aSlpaaa2WWnGmbmJvIb3FhlpphnMqVZnFonmxr
- Check this key: https://www.security-master-key.com.
------------------------
Full and original release in PDF format:
https://www.actusnews.com/documents_communiques/ACTUS-0-87975-pr_hy2024_final.pdf

© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
© 2024 Actusnews Wire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.